News
31m
Investor's Business Daily on MSNCollegium Pharmaceutical Earns Membership In 95-Plus Composite Rating ClubCollegium Pharmaceutical earns the No. 2 rank among its peers in the Medical-Generic Drugs industry group. ANI ...
37m
Investor's Business Daily on MSNIBD Rating Upgrades: Collegium Pharmaceutical Flashes Improved Relative Price StrengthCollegium Pharmaceutical shows rising price performance, earning an upgrade to its IBD Relative Strength Rating ...
As tariffs on drug imports from the EU look set to alter pricing and manufacturing strategies, each entity needs to study its full impact.
TO APPRECIATE the dilemmas the Food and Drug Administration (FDA) faces when it reviews new drugs targeting rare diseases, ...
Plus more pharma news from the Pharmalittle newsletter.
Elias Zerhouni tells Chemistry World what's changed from when he was appointed by a Republican president to the current Trump ...
Thermoplastic elastomers (TPE) offer a PFAS-free solution for stoppers in parenteral packaging, ensuring a safer and more ...
This episode of Pharma Pulse explores the FDA’s new proactive quality review initiative for drug manufacturing, GSK’s $370 ...
Nomura’s June 2025 analysis shows Indian pharma majors like Sun Pharma, Dr. Reddy’s, Cipla, Lupin, and Zydus posting strong ...
European supplement manufacturing is booming but finding manufacturers who actually deliver quality products consistently is ...
Some of Philadelphia’s biotechnology companies that specialize in cell therapy shed employees in recent weeks as the industry is facing some unique headwinds.
Boehringer's Hernexeos is now FDA-approved for patients with HER2-positive NSCLC, bringing it into direct competition with ADC Enhertu.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results